stock analyst


Click to enlarge

Quick Take

Electronics manufacturer Microphase (Pending:MPHSE) has filed an amended S-1 registration statement with notable new details.

The company experienced a severe drop in revenues and in gross margin in Q3 2016 due to a combination of factors within its control and outside its control.

Microphase has not yet provided an expected price range for its IPO stock, but given the 44% drop in quarterly revenue in 3Q 2016 vs. the same quarter in 2015, investors should be concerned about the company’s exposure to supply chain vulnerabilities and logistics issues.

stock analyst: DRDGOLD Limited(DRD)


Advisors’ Opinion:

  • [By Lisa Levin]

    Tuesday afternoon, the basic materials sector proved to be a source of strength for the market. Leading the sector was strength from Endeavour Silver Corp (NYSE: EXK) and DRDGOLD Ltd. (ADR) (NYSE: DRD).

  • [By Alex McGuire]

    This list ranks gold dividend stocks in the mining sector by dividend yield. And it also includes one of our top gold stock recommendations of 2017…

    Gold Dividend Stock Share Price Year-to-Date Performance Dividend Yield (as of June 30) DRDGOLD Ltd. (NYSE ADR: DRD) $3.19 -39.7% 10.24% Sibanye Gold Ltd. (NYSE ADR: SBGL) $4.70 -33.4% 5.98% Harmony Gold Mining Co. (NYSE ADR: HMY) $1.62 -26.7% 4.56% Gold Fields Limited (NYSE ADR: GFI) $3.41 +13.3% 2.73% Randgold Resources Ltd. (Nasdaq ADR: GOLD) $87.68 +14.9% 1.89% Franco Nevada Corp. (NYSE: FNV) $72.39 +21.1% 1.27% Royal Gold Inc. (Nasdaq: RGLD) $76.85 +21.3% 1.25% Eldorado Gold Corp. (NYSE: EGO) $2.58 -19.9% 1.16% Barrick Gold Corp. (NYSE: ABX) $15.90 -0.5% 0.75% Goldcorp Inc. (NYSE: GG) $13.02 -4.4% 0.62%


    Six of the 10 gold stocks listed above have posted negative returns so far in 2017. The main reason behind their losses has to do with gold price volatility.

  • [By Lisa Levin]

    In trading on Wednesday, basic materials shares fell by 1.27 percent. Meanwhile, top losers in the sector included McEwen Mining Inc (NYSE: MUX), down 12 percent, and DRDGOLD Ltd. (ADR) (NYSE: DRD), down 7 percent.

stock analyst: McDermott International, Inc.(MDR)


Advisors’ Opinion:

  • [By Monica Gerson]

    McDermott International Inc. (NYSE: MDR) reported stronger-than-expected results for its first quarter and lifted its 2016 earnings outlook. McDermott shares jumped 8.45 percent to $4.43 in the after-hours trading session.

  • [By Monica Gerson]

    Benzinga's newsdesk monitors options activity to notice unusual patterns. These large volume (and often out of the money) trades were initially published intraday in Benzinga Professional . These trades were placed during Thursday's regular session.

stock analyst: Sarepta Therapeutics, Inc.(SRPT)


Advisors’ Opinion:

  • [By Ben Levisohn]

    After surveying 30 neurologists, Baird’s Brian Skorney and Neena Bitritto-Garg contend that the Street might be underestimating sales of Sarepta Therapeutics (SRPT) Exondys 51 treatment for patients with Duchenne muscular dystrophy. They explain why:

  • [By Johanna Bennett]

    Will healthinsurers pay for Sarepta Therapeutics (SRPT) Exondys 51?


    Thats a question that several analysts have weighed on today. It appears that payors are still actively evaluating and reevaluating coverage of the Duchenne muscular dystrophy drug Exondys 51.

    Approved by the FDA in September, the drug has met with widespread pushback from insurers like Anthem (ANTM), Humana (HUM) and UnitedHealth Group (UNH) amid concerns about its efficacy. So while Sareptas share price has more than doubled over the past 12 months, it has made a sharp retreat, falling 50% to just under $32 a share since hitting a record high $63.73 a share in late September.


    But Cowen analyst Ritu Baral says the tide maybe turning, arguing that coverage denials wont be permanent.

    As SRPT management and our Neuromuscular Disease panelist indicated to us at our recent Healthcare Conference, payor discussions are continuing regarding Exondys 51 with manageable, increasingly positive feedback. Of the major plans we have seen coverage policies released for, only Anthem (including Blue Cross Blue Shield) had previously denied coverage of Exondys, though patients could petition for coverage via a standard appeal process (see further below). Based on their February Specialty Pharmacy Medical Management Prior Authorization Drug List, it appears Anthem will add Exondys 51 to its prior auth list as of 5/1. We think this is encouraging and indicative of the evolving payor landscape surrounding Exondys 51 and more broadly, DMD. Anthem’s pick-up, together with those such as United, which started coverage on 2/1, support the idea of accelerating new patient starts, suggested by SRPT last week at our Healthcare Conference.


    …But Coverage Denials Persist (For Now), Especially Among Non-Ambulatory Patients. While we think the overwhelming majority of amenable patients will eventually be covered for Exondys 51, we do note several social media anecdote

  • [By Dan Caplinger]

    Yet some stocks didn’t participate in the rally, instead contending with negative news of their own. Zoe’s Kitchen (NYSE:ZOES), GOL Lineas Aereas Inteligentes (NYSE:GOL), and Sarepta Therapeutics (NASDAQ:SRPT) were among the worst performers on the day. Below, we’ll look more closely at these stocks to tell you why they did so poorly.

stock analyst: PDC Energy, Inc.(PDCE)


Advisors’ Opinion:

  • [By Ben Levisohn]

    Names which screen well on a combination of attractive valuation and equitized capital structure, include Outperform rated Apache, Anadarko Petroleum,Gulfport Energy as well as Market Perform rated QEP Resources (QEP) and PDC Energy (PDCE).

  • [By Ben Levisohn]

    Goldman Sachs analyst Brian Singer and team contend that EOG Resources (EOG), Diamondback Energy (FANG), PDC Energy (PDCE), Pioneer Natural Resources (PXD), and RSP Permian (RSPP) can benefit from greater productivity. They explain:

stock analyst: GigaMedia Limited(GIGM)


Advisors’ Opinion:

  • [By Jim Robertson]

    Today, our Under the Radar Moversnewsletter suggested small cap online gaming and cloud computing GigaMedia Limited (NASDAQ: GIGM) as a bullish long trade:

stock analyst: NRG Energy Inc.(NRG)

Advisors’ Opinion:

  • [By Lisa Levin]

    Non-cyclical consumer goods & services sector was the top gainer in the US market on Wednesday. Top gainers in the sector included Cia Energetica de Minas Gerais CEMIG-ADR (NYSE: CIG), Companhia Paranaense de Energia (ADR) (NYSE: ELP), and NRG Energy Inc (NYSE: NRG).

  • [By Lisa Levin]

    Benzinga's newsdesk monitors options activity to notice unusual patterns. These large volume (and often out of the money) trades were initially published intraday in Benzinga Professional . These trades were placed during Thursday’s regular session.

  • [By Chris Lange]

    The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Thursday was NRG Energy, Inc. (NYSE: NRG) which rose over 5% to $22.20. The stocks 52-week range is $9.84 to $23.36. Volume was over 35 million compared to its average volume of 5.8 million.

  • [By Ben Levisohn]

    NRG Energy (NRG) has gained 2.1% to $18.49 after getting raise to Buy from Neutral at Goldman Sachs.

    Skechers USA (SKX) has tumbled 5.4% to$28.35 after getting cut to Negative from Positive at Susquehanna.

Leave a Reply

Your email address will not be published. Required fields are marked *